Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Bacon

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Gastroenterology|August 9, 2005
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registryKris V Kowdley, David J Brandhagen, Robert G Gish, et al.
Journal of Hepatology|February 6, 2010
Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosisAnita C G Chua, Roheeth D Delima, Evan H Morgan, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virusJohn G McHutchison, Bruce R Bacon, Stuart C Gordon, et al.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV InfectionSteven Flamm, K Rajender Reddy, Neddie Zadeikis, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infectionFred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2010
An explicit quality indicator set for measurement of quality of care in patients with cirrhosisFasiha Kanwal, Jennifer Kramer, Steven M Asch, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1Stefan Zeuzem, Mark S Sulkowski, Eric J Lawitz, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Gastroenterology|August 9, 2005
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registryKris V Kowdley, David J Brandhagen, Robert G Gish, et al.
Journal of Hepatology|February 6, 2010
Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosisAnita C G Chua, Roheeth D Delima, Evan H Morgan, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virusJohn G McHutchison, Bruce R Bacon, Stuart C Gordon, et al.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV InfectionSteven Flamm, K Rajender Reddy, Neddie Zadeikis, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infectionFred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2010
An explicit quality indicator set for measurement of quality of care in patients with cirrhosisFasiha Kanwal, Jennifer Kramer, Steven M Asch, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1Stefan Zeuzem, Mark S Sulkowski, Eric J Lawitz, et al.
Pageof 12